News

Bank7 Corp's Remarkable Financial Performance in Q2 2025

Bank7 Corp's Remarkable Financial Performance in Q2 2025

Bank7 Corp. Reports Strong Q2 Financials

Bank7 Corp. (NASDAQ: BSVN) has recently unveiled its robust financial results for the quarter ending June 30, 2025. The success of this quarter is characterized by significant growth in organic loans and deposits, demonstrating the bank's resilience despite economic challenges. According to Thomas L. Travis, the President and CEO, the company's strong capital ratios and excellent credit quality underscore a well-matched balance sheet, which supports their sustainable growth strategy.

Quarterly Highlights

For the three-month period that concluded on June 30, 2025, Bank7 reported the following key financial metrics:

  • Net income rose to $11.1 million, a 7.44% increase from $10.3 million in the previous quarter.
  • Earnings per share climbed to $1.16, up by 7.41% from $1.08.
  • Total assets remained strong at $1.8 billion, with a 2.83% growth.
  • The total loans increased by 5.17%, reaching $1.5 billion.
  • Pre-tax, pre-provision earnings (PPE) stood at $14.7 million, reflecting a growth of 7.25% compared to previous results.
  • Interest income for this quarter was reported at $31.8 million, an increase of 4.41% from $30.4 million.

Capital Ratios and Compliance

The capital levels of both the Bank and the Company are significantly above the minimum thresholds that define a 'well-capitalized' institution. As of June 30, 2025, the consolidated Tier 1 leverage ratio was noted at 12.49%. Furthermore, both the Tier 1 risk-based capital ratio and total risk-based capital ratio stood at approximately 13.90% and 15.03%, respectively. These ratios affirm Bank7's commitment to maintaining strong capital support and adhering to regulatory requirements.

Understanding Non-GAAP Measures

This earnings report also highlights the relevance of the non-GAAP financial measure known as pre-provision pre-tax earnings, or PPE. This specific measure aids management in analyzing the true performance of the company by stripping away variables such as income tax expenses and provisions for credit losses.

About Bank7 Corp.

Bank7 Corp. is a bank holding company that operates numerous branches across targeted markets. The company focuses on providing tailored financial services to business owners and entrepreneurs, emphasizing rapid and dependable service. In addition to expanding its footprint, Bank7 is committed to nurturing organic growth through strategic acquisitions.

Conference Call Details

Bank7 Corp. has scheduled a conference call on July 17, 2025, at 9:00 a.m. CST to discuss its second quarter results further. Participants can dial in or access the live stream online, allowing for an interactive discussion about the company's performance.

Contact Information

Thomas Travis
President & CEO
(405) 810-8600

Frequently Asked Questions

What were the net earnings for Bank7 Corp. in Q2 2025?

Bank7 Corp. reported net earnings of $11.1 million for the quarter ending June 30, 2025.

How much did the bank's total loans increase?

Total loans rose by 5.17%, reaching approximately $1.5 billion.

What are the bank's key financial ratios?

The Tier 1 leverage ratio is 12.49%, and both the Tier 1 risk-based capital ratio and total risk-based capital ratio are at 13.90% and 15.03%, respectively.

What are non-GAAP financial measures?

Non-GAAP measures, like pre-provision pre-tax earnings (PPE), are used to provide a clearer picture of a company's performance by eliminating certain variables like tax expenses.

Who can I contact for more information on Bank7 Corp.?

You can contact Thomas Travis, the President & CEO, at (405) 810-8600 for more information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 170

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 211

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 268

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 227

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 234

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 84

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 186

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 193

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of the Sodium Bisulfite Market by 2034

Updated Category News Views 133

Understanding the Growth of the Sodium Bisulfite Market The sodium bisulfite market is experiencing significant momentum as it progresses towards a bright future, with expectations of reaching USD 1,180.7 million by 2034, up from USD 750.3 million in 2024. This growth is driven by an increasing awareness of environmental issues and its versatile applications in various...

Continue Reading
Photocure ASA Reports Impressive Q2 Growth and Outlook

Updated Category News Views 153

Photocure ASA Achieves Record Revenue in Q2 Photocure ASA has shared strong results for the second quarter of the year, showcasing remarkable growth in its Hexvix/Cysview product line. This quarter marked an unprecedented achievement with revenues reaching NOK 135.6 million, reflecting a significant increase compared to NOK 122.4 million from the same period last year....

Continue Reading
Ben & Jerry's Unveils New Flavor Inspired by Noah Kahan

Updated Category News Views 273

Ben & Jerry's Launches Exclusive Flavor with Noah Kahan Ben & Jerry's, the iconic ice cream brand that loves to explore creative flavors, has just introduced an exciting new flavor called Northern Latte-tude. This one-of-a-kind creation is the result of a collaboration with musician Noah Kahan, with the goal of not only delighting fans but also supporting an important...

Continue Reading
Cisco Analyst Coverage Initiation Highlights: Stocks to Watch

Updated Category News Views 141

Latest Analyst Ratings on Notable Stocks In a dynamic market environment, top analysts analyze and provide insights on various companies. Recently, several key analysts have shared significant ratings and price targets for notable stocks, including Cisco Systems, Inc. (NASDAQ: CSCO) and Shopify Inc. (NASDAQ: SHOP). Let's delve into what they have to say. Shopify Inc....

Continue Reading
Nike's Leadership Shakeup: A Bright Future Ahead for the Brand

Updated Category News Views 205

Nike's Steady Outlook Amid Leadership Changes BMO Capital Markets has recently reaffirmed its Outperform rating for Nike Inc. (NYSE:NKE), setting a price target at $92.00 per share. This positive outlook follows the recent appointment of Elliott Hill as President and CEO, a change many investors have eagerly awaited. Hill's return is seen as a hopeful sign for the...

Continue Reading